Life Science Company News

Reset
Results 1 - 20 out of 500 displayed.
1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »

Novo Nordisk A/S – Total number of voting rights and share capital in Novo Nordisk A/S as of 26 April 2024

Read more ››
By: GlobeNewswire - 26 Apr 2024

Ocugen to Present on Modifier Gene Therapy Platform at Association for Research in Vision and Ophthalmology 2024 Annual Meeting

Read more ››
By: GlobeNewswire - 26 Apr 2024
Related companies:  Ocugen, Inc.

Interactive Strength Inc. (Nasdaq: TRNR) Strengthens Balance Sheet by Partially Converting Senior Loan to Equity and Extending the Maturity

Read more ››
By: GlobeNewswire - 26 Apr 2024

Krystal Biotech to Report First Quarter 2024 Financial Results on May 6, 2024

Read more ››
By: GlobeNewswire - 26 Apr 2024
Related companies:  Krystal Biotech, Inc.

Y-mAbs to Announce First Quarter 2024 Financial and Operating Results on May 7, 2024

Read more ››
By: GlobeNewswire - 26 Apr 2024
Related companies:  Y-mAbs Therapeutics Inc.

Apellis Announces Pegcetacoplan MAA Review Has Been Reset to Day 180 of Initial Assessment by European Medicines Agency (EMA)

Read more ››
By: GlobeNewswire - 26 Apr 2024
Related companies:  Apellis Pharmaceuticals, Inc.

CG Oncology to Host Virtual Investor Event on Friday, May 3, 2024

Read more ››
By: GlobeNewswire - 26 Apr 2024
Related companies:  CG Oncology, Inc.

Cidara Therapeutics Announces Presentations Highlighting Phase 1 and Phase 2a Clinical Data on CD388 at ESCMID 2024

Read more ››
By: GlobeNewswire - 26 Apr 2024
Related companies:  Cidara Therapeutics, Inc.

Neurosurgery Customer from Germany Orders Nexstim NBS System 5

Read more ››
By: GlobeNewswire - 26 Apr 2024
Related companies:  Nexstim Plc

Medicenna Therapeutics Announces CA$20 Million Investment from RA Capital Management

Read more ››
By: GlobeNewswire - 26 Apr 2024
Related companies:  Medicenna Therapeutics Corp.

HUTCHMED Announces Positive CHMP Opinion for Fruquintinib in Previously Treated Metastatic Colorectal Cancer Received by Takeda

Read more ››
By: GlobeNewswire - 26 Apr 2024
Related companies:  HUTCHMED

Exagen Inc. Announces Changes to the Board of Directors

Read more ››
By: GlobeNewswire - 26 Apr 2024
Related companies:  Exagen Inc.

Biodexa Enters Into Exclusive License to eRapa™, a Phase 3 Ready Asset for the Treatment of Familial Adenomatous Polyposis (FAP)

Read more ››
By: GlobeNewswire - 26 Apr 2024
Related companies:  Biodexa Pharmaceuticals PLC

Allogene Therapeutics Awarded Grant from the California Institute for Regenerative Medicine to Advance Development of an Allogeneic CAR T in Renal Cell Carcinoma

Read more ››
By: GlobeNewswire - 26 Apr 2024
Related companies:  Allogene Therapeutics, Inc.

Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)

Read more ››
By: GlobeNewswire - 26 Apr 2024
Related companies:  Orion Oyj

Ibogaine By David Dardashti Begins Inflammation Tests to Demonstrate Adequate Results

Read more ››
By: GlobeNewswire - 26 Apr 2024

UPDATE -- Ocugen to Present on Modifier Gene Therapy Platform at Association for Research in Vision and Ophthalmology 2024 Annual Meeting

Read more ››
By: GlobeNewswire - 26 Apr 2024
Related companies:  Ocugen, Inc.

Capsa’s New NexPak Addresses Medication Administration Efficiencies In Correctional Care

Read more ››
By: GlobeNewswire - 26 Apr 2024
Related companies:  Capsa Healthcare

Range Impact Transitions Two Executives to Graphium Biosciences Subsidiary as Part of Proposed Divestiture and Promotes Corporate Controller to Chief Financial Officer

Read more ››
By: GlobeNewswire - 26 Apr 2024

Tevogen Bio CEO Highlights Expected Reporting of a $94.9 Million Liability Elimination, AI Initiative, and Leadership Appointments

Read more ››
By: GlobeNewswire - 26 Apr 2024
Results 1 - 20 out of 500 displayed.
1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »

Enhance your business development with Biotechgate
Try for free »